At close: June 14 at 3:59 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Linda F. Powers J.D. | Chairperson, CEO, President, CFO & Chief Accounting Officer | 925k | -- | 1956 |
| Dr. Alton L. Boynton Ph.D. | Founder, Chief Scientific Officer, Secretary & Director | 375k | -- | 1945 |
| Dr. Marnix L. Bosch M.B.A., Ph.D. | Chief Technical Officer | 453.6k | 74k | 1959 |
| Mr. Leslie J. Goldman | Senior VP & General Counsel | 725k | -- | 1945 |
| Mr. David Innes | Vice President of Investor Relations | -- | -- | -- |
Northwest Biotherapeutics, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 25
Description
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.
Corporate Governance
Northwest Biotherapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 7, 2024 at 8:00 PM UTC - August 12, 2024 at 8:00 PM UTC
Northwest Biotherapeutics, Inc. Earnings Date
Recent Events
Related Tickers
CVM CEL-SCI Corporation
1.3000
+0.78%
ANVS Annovis Bio, Inc.
5.85
-2.66%
AVXL Anavex Life Sciences Corp.
3.7700
+1.07%
ATNM Actinium Pharmaceuticals, Inc.
7.82
-2.49%
CERO CERo Therapeutics Holdings, Inc.
0.3799
+5.65%
ALDX Aldeyra Therapeutics, Inc.
3.7300
-3.37%
CYDY CytoDyn Inc.
0.1350
-1.39%
SLS SELLAS Life Sciences Group, Inc.
1.5000
+3.45%
CDIO Cardio Diagnostics Holdings, Inc.
0.5980
-0.66%
CNSP CNS Pharmaceuticals, Inc.
2.7900
-22.93%